SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-1.1
Date Filed: 2025-08-27
Accession Number: 0001213900-25-081175
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025081175/ea025480001ex1-1_synergy.htm

Chunk 7 of 27
Word Count: 1391
Character Count: 8658

Document Content:

be in a position to help or hinder the business of the Company or any of its Subsidiaries (or assist any of them in connection with any actual or proposed transaction) that (i) might subject the Company or any of its Subsidiaries to any damage or penalty in any civil, criminal or governmental litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in the future, might adversely affect the assets, business, operations or prospects of the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the Convention on Combating Bribery of Foreign Public Officials in International Business Transactions of the Organisation for Economic Co-operation and Development (OECD).

(xix) Compliance
with Sanctions Laws. None of the Company, any of its Subsidiaries or, to the knowledge of the Company, any directors, officers or
employees of the Company or any of its Subsidiaries or any agent, affiliate or other person associated with or acting on behalf of the
Company or any of its Subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. government,
(including, without limitation, the Office of Foreign Assets Control (OFAC) of the U.S. Department of the Treasury or the U.S. Department
of State and including, without limitation, the designation as a “specially designated national” or “blocked person”),
the United Nations Security Council, the European Union, the Office of Financial Sanctions Implementation of the United Kingdom of Great
Britain and Northern Ireland (OFSI) or other relevant sanctions authority (collectively, “Sanctions”), nor is the Company
or any of its Subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including,
without limitation, the Republic of Belarus, Crimea, the Russian Federation, Republic of Cuba, the Islamic Republic of Iran, Democratic
People’s Republic of Korea (North Korea), the Libyan Arab Republic, the Syrian Arab Republic, the Bolivarian Republic of Venezuela
and the Republic of Yemen (each, a “Sanctioned Country”); and the Company will not directly or indirectly use the proceeds
of the Offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or other person
or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is
the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any
other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter,
advisor, investor or otherwise) of Sanctions. For the past three years, the Company has not knowingly engaged in and is not now knowingly
engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target
of Sanctions or with any Sanctioned Country.

(xx) Insurance.
The Company and each of its Subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as is adequate for
the conduct of its business and the value of its properties and as is customary for companies engaged in similar businesses in similar
industries.

(xxi) Books and
Records. The minute books of the Company and each of its Subsidiaries have been made available to the Representative and counsel for
the Underwriters, and such books accurately in all material respects reflect all transactions referred to in such minutes.

(xxii) No Undisclosed
Contracts. There is no Contract or document required by the Securities Act or by the Rules and Regulations to be described in the
Registration Statement, the Time of Sale Disclosure Package or in the Final Prospectus or to be filed as an exhibit to the Registration
Statements which is not so described or filed therein as required; and all descriptions of any such Contracts or documents contained in
the Registration Statement, the Time of Sale Disclosure Package and in the Final Prospectus are accurate and complete descriptions of
such documents in all material respects. Other than as described in the Registration Statement, the Time of Sale Disclosure Package and
the Final Prospectus, no such Contract has been suspended or terminated for convenience or default by the Company or any Subsidiary party
thereto or any of the other parties thereto, and neither the Company nor any of its Subsidiaries has received notice, and the Company
has no knowledge, of any such pending or threatened suspension or termination.

(xxiii) No Undisclosed
Relationships. No relationship, direct or indirect, exists between or among the Company or any of its Subsidiaries on the one hand,
and the directors, officers, stockholders (or analogous interest holders), customers or suppliers of the Company or any of its Subsidiaries
on the other hand, which is required to be described in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus
and which is not so described.

(xxiv) Insider
Transactions. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business)
or guarantees of indebtedness by the Company or any of its Subsidiaries to or for the benefit of any of the officers or directors of the
Company, any of its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement, the Time
of Sale Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company
have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof, if and to the extent
required under applicable law.

(xxv) No Registration
Rights. No person or entity has the right to require registration of Common Stock or other securities of the Company or any of its
Subsidiaries within 180 days of the date hereof because of the filing or effectiveness of the Registration Statement or otherwise, except
for persons and entities who have expressly waived such right in writing or who have been given timely and proper written notice and have
failed to exercise such right within the time or times required under the terms and conditions of such right. Except as described in the
Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, there are no persons with registration rights or
similar rights to have any securities registered by the Company or any of its Subsidiaries under the Securities Act.

(xxvi) Continued
Business. No supplier, customer, distributor or sales agent of the Company or any Subsidiary has notified the Company or any Subsidiary
that it intends to discontinue or decrease the rate of business done with the Company or any Subsidiary, except where such discontinuation
or decrease has not resulted in and could not reasonably be expected to result in a Material Adverse Effect.

(xxvii) No Finder’s
Fee. There are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder’s, consulting
or origination fee by the Company or any officer or director of the Company with respect to the sale of the Shares hereunder or any other
arrangements, agreements or understandings of the Company or, to the Company’s knowledge, any of its shareholders that may affect
the Underwriters’ compensation, as determined by FINRA.

(xxviii) No Fees.
The Company has not made any direct or indirect payments (in cash, securities or otherwise) in connection with the Offering to: (i) any
person, as a finder’s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing
to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any
direct or indirect affiliation or association with any FINRA member, within the twelve (12) months prior to the Effective Time, other
than the payment to the Underwriters as provided hereunder in connection with the Offering.

(xxix) Proceeds.
None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or any affiliate or associate of
any participating FINRA member, except as specifically authorized herein.